1. Academic Validation
  2. Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis

  • J Mol Cell Biol. 2022 Jan 21;13(11):834-837. doi: 10.1093/jmcb/mjab054.
McKay Mullen 1 2 Fengrui Yang 1 2 Jun Cao 1 Yang Cao 3 Xu Liu 1 2 Gee Young Lee 2 Tao Li 1 4 William Yao 4 Zhihong Yang 1 Jiahai Zhang 1 Kela Johnson 2 Felix Aikhionbare 2 Yong Chen 3 Xinjiao Gao 1 Dongmei Wang 1 Xia Ding 4 Hadiyah-Nicole Green 2 5 Xing Liu 1 2 Xuebiao Yao 1 2
Affiliations

Affiliations

  • 1 MOE Key Laboratory for Cellular Dynamics, Anhui Key Laboratory for Chemical Biology, CAS Center for Excellence in Molecular Cell Science, University of Science and Technology of China, Hefei 230027, China.
  • 2 Keck Center for Oganoids Plasticity, Morehouse School of Medicine, Atlanta, GA 30310, USA.
  • 3 Department of Hepatobiliary Surgery, Xijing Hospital, Xi'an 710032, China.
  • 4 BUCM-USTC Collaborative Center for Parietal Cell Research, Beijing University of Chinese Medicine, Beijing 100029, China.
  • 5 Ora Lee Smith Cancer Research Foundation, Atlanta, GA 30310, USA.
Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-121569
    98.25%, CENP-E 抑制剂